SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,584,385 | -43.6% | 2,006,451 | 0.0% | 0.04% | -43.6% |
Q2 2023 | $13,443,222 | +2.9% | 2,006,451 | 0.0% | 0.08% | +9.9% |
Q1 2023 | $13,061,996 | -23.7% | 2,006,451 | 0.0% | 0.07% | -31.1% |
Q4 2022 | $17,115,027 | +132.7% | 2,006,451 | +742.7% | 0.10% | +221.9% |
Q2 2021 | $7,355,000 | -29.2% | 238,095 | 0.0% | 0.03% | -28.9% |
Q1 2021 | $10,388,000 | -5.8% | 238,095 | 0.0% | 0.04% | +7.1% |
Q4 2020 | $11,033,000 | – | 238,095 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |